Tag: sk bioscience

sk bioscience

Latest News

Trevor Mundel, third from left, president of Global Health at the Gates Foundation; Chey Chang-won, fourth from left, vice chairman of SK discovery; and Ahn Jae-yong, fifth from left, CEO of SK bioscience, pose with other officials after a meeting on global health projects in Seoul. [SK BIOSCIENCE]

SK bioscience, Gates Foundation to deepen cooperation on global health

SK bioscience Co., the biotech arm of Korea's SK Group, said Thursday it will expand cooperation with the Gates Foundation on next-generation preventive medicines, with a focus on research and development (R&D) for pandemic preparedness.

2025.8.21

Federico Pollano was appointed as the new chief commercial officer of IDT Biologika in March 2025. [IDT BIOLOGIKA]

'Strong synergies': IDT Biologika expands SK bioscience's global reach into new projects

BOSTON — SK bioscience’s acquisition of German contract manufacturer IDT Biologika last year was a strategic play to globalize its drug manufacturing footprint and tap into IDT’s century-old client base.

2025.6.18

Most popular

Researchers at SK bioscience analyze their findings in a photo shared by the company on Feb. 12. [YONHAP]

SK bioscience wins patent dispute against Pfizer over pneumococcal vaccine

SK bioscience, a biotech arm of Korea's SK Group, said Wednesday it has won a patent lawsuit against global pharmaceutical giant Pfizer over pneumococcal vaccine components.

2025.5.21

SK bioscience researchers analyze their findings in a photo shared by the company on Feb. 12. [YONHAP]

SK bioscience wins patent case against Moderna in Korea

SK bioscience won a patent case against Moderna in Korea, impacting mRNA technology development and potential vaccine exports to developing countries.

2025.4.23

SK Bioscience CEO Ahn Jae-yong, left, and Sanofi's Jean-Francois Toussant, global head of vaccine research and development, pose for the photo after a signing ceremony. [SK BIOSCIENCE]

SK bioscience and Sanofi extend partnership to develop next-gen vaccines

SK bioscience and Sanofi, a global healthcare company, extended their partnership to co-develop next-generation pneumococcal conjugate vaccines (PCVs) for both pediatric and adult populations, the bio company said on Monday.

2024.12.23

SK bioscience's cell-cultured influenza vaccine SKYCellflu [SK BIOSCIENCE]

SK bioscience's flu vaccine gets green light from Indonesia

SK bioscience's SKYCellflu, a cell-cultured influenza vaccine, has been approved by Indonesia's Food and Drug Authority.

2024.10.23

SK bioscience to invest $3 million to Fina Biosolutions

SK bioscience will invest $3 million in Fina Biosolutions, a Maryland-based conjugate vaccine developer, the Korean company said Tuesday.

2024.10.8

SK bioscience researchers conduct tests at L House, the company’s vaccine manufacturing facility in Andong, North Gyeongsang. [SK BIOSCIENCE]

SK bioscience banks on shingles vaccine as market gap opens and summer arrives

SK bioscience is seeking a breakthrough with its shingles vaccine amid anticipated summer demand and longtime rival MSD's withdrawal from the shingles vaccine market.

2024.6.3

A bird's-eye view of SK bioscience's vaccine facility in Songdo, Incheon [SK BIOSCIENCE]

SK bioscience applies for emergency Covid-19 vaccine approval

SK bioscience has applied for emergency use approval for Novavax’s updated Covid-19 vaccine.

2023.10.20

Pre-filled syringes of SKYCellflu influenza vaccine on the packaging line at SK bioscience’s Andong L House manufacturing plant in North Gyeongsang on Tuesday [SHIN HA-NEE]

SK bioscience restarts flu shot production after 2 years

The flu season is back in full swing, and so is SK bioscience’s production of Korea’s first and only cell-based influenza vaccine.

2023.8.23